Christopher Townsend
Directeur/Bestuurslid bij OCEAN WILSONS HOLDINGS LIMITED
Vermogen: 72 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| William Salomon | M | 66 |
Ocean Wilsons (Investments) Ltd.
| 29 jaar |
| Keith W. Middleton | M | - |
Ocean Wilsons (Investments) Ltd.
| 26 jaar |
| Caroline Foulger | F | 63 |
Ocean Wilsons (Investments) Ltd.
| 4 jaar |
| José Francisco Gouvêa Vieira | M | 74 | 33 jaar | |
| Fernando Fleury Salek | M | 55 | 8 jaar | |
| Augusto Cezar Tavares Baião | M | 64 | 30 jaar | |
| Andrey Berzins | M | 65 |
Ocean Wilsons (Investments) Ltd.
| 10 jaar |
| Fiona Beck | F | 59 |
Ocean Wilsons (Investments) Ltd.
| 4 jaar |
| Leslie Rans | F | - | 3 jaar | |
| Mauro Moreira | M | 64 | 4 jaar | |
| Frank Tegtmeier | M | - |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | 23 jaar |
| Cláudio Roberto Frischtak | M | 74 | - | |
| Michael Robert Connell | M | 48 | - | |
| Reinhard Schinzel | M | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | 22 jaar |
| Arnaldo Calbucci Filho | M | 67 | 44 jaar | |
| Peter Scheurer | M | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | 22 jaar |
| Andrew John Matthew Clark | M | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | - |
| Roberto Barzi | M | 48 |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | - |
| Christian Leikert | M | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | - |
| Christian Wandersee | M | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | 25 jaar |
| Victor Paranhos | M | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Colin C. Maltby | M | 74 | 8 jaar | |
| Charles Forster Alexander Cooper | M | 81 | 20 jaar | |
| Fabricia Gomes de Souza | F | 52 | - | |
| Fergus McAleavey | M | - | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Bermuda | 10 | 40.00% |
| Brazilië | 10 | 40.00% |
| Duitsland | 7 | 28.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Christopher Townsend
- Persoonlijk netwerk
